PLK1 and neoplasm: In particular, tumors with elevated expression of PLK1 displayed lower immune activity, such as lower expression of Human Leukocyte Antigens (HLA), fewer B cells, NK cells and tumor-infiltrating lymphocytes and reduction of T-regulatory cells.